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Paget’s disease (PD) is characterized by abnormal
osteoclasts (OCL) that secrete high IL-6 levels and
induce exuberant bone formation. Because measles
virus nucleocapsid gene (MVNP) and the p62P392L
mutation are implicated in PD, marrows from 12 PD
patients harboring p62P392L and eight normals were
tested for MVNP expression and pagetic OCL forma-
tion. Eight out of twelve patients expressed MVNP
and formed pagetic OCL in vitro, which were in-
hibited by antisense-MVNP. Four out of twelve
patients lacked MVNP and formed normal OCL that
were hyperresponsive to RANKL but unaffected by
antisense-MVNP. Similarly, mice expressing only
p62P394L formed normal OCL, while mice expressing
MVNP in OCL, with or without p62P394L, developed
pagetic OCL and expressed high IL-6 levels depen-
dent on p38MAPK activation. IL-6 deficiency in
MVNP mice abrogated pagetic OCL development
in vitro. Mice coexpressing MVNP and p62P394L
developed dramatic Paget’s-like bone lesions. These
results suggest that p62P394L and IL-6 induction by
MVNP play key roles in PD.
INTRODUCTION
Paget’s disease (PD) is characterized by highly localized areas of
increased bone resorption coupled to exuberant new bone
formation with the primary cellular abnormality in the osteoclasts
(OCL) (Roodman and Windle, 2005). OCL in PD are increased in
number and size and express a ‘‘pagetic phenotype’’ that distin-
guishes them from normal OCL. They contain up to 100 nuclei/
OCL compared to three to ten nuclei/OCL in normals.
Their precursors are hyperresponsive to RANKL, TNF-a, and
1,25(OH)2D3, and form OCL at physiologic concentrations ofC1,25(OH)2D3 (10
11M) rather than the pharmacologic 1,25
(OH)2D3 concentrations (10
8M) required for normal OCL forma-
tion in vitro (Kukita et al., 1990; Kurihara et al., 2004;Menaa et al.,
2000). The 1,25(OH)2D3 hyperresponsivity results from elevated
levels of a VDR coactivator, TAF12 (formerly TAFII-17) in OCL
(Kurihara et al., 2004). Further, OCL in PD secrete high levels
of IL-6, which are detectable in marrow plasma and peripheral
blood from PD patients (Roodman et al., 1992).
At least 21 mutations in sequestosome 1/p62, a scaffold
protein that plays a key role in RANKL signaling in OCL, are
linked to PD, with p62P392L the most frequent mutation found
(Laurin et al., 2002; Morissette et al., 2006; Ralston, 2002).
However, the role of p62P392L in PD is unclear because normal
OCL precursors expressing p62P392L are hyperresponsive to
RANKL but not to 1,25(OH)2D3, and do not express high levels
of IL-6 or TAF12 or form bone lesions or OCL characteristic of
PD (Hiruma et al., 2008; Kurihara et al., 2007).
Various environmental factors, including measles virus and
other paramyxoviruses, have also been implicated in the patho-
genesis of PD. We previously found that OCL from 70% of PD
patients expressed the measles virus nucleocapsid protein
(MVNP) gene, and that normal OCL precursors expressing
MVNP formed OCL that exhibit the ‘‘pagetic phenotype’’ (Kuri-
hara et al., 2000). Further, 29% of transgenic mice with targeted
expression of MVNP to OCL (MVNP mice) developed OCL and
bone lesions characteristic of PD (Kurihara et al., 2006).
Therefore, to assess the relative contributions of MVNP and
p62P392L in PD, marrows from clinically involved and uninvolved
bones of PD patients with p62P392L or normals were tested
for MVNP expression and the effects of antisense-MVNP
(AS-MVNP) on the OCL formed determined. To delineate the
mechanism(s) responsible for the abnormal OCL activity and
bone formation seen with coexpression of MVNP and mutant
p62, p62P394L knockin (p62KI) mice (the mouse equivalent of
human p62P392L) were bred to TRAP-MVNP transgenic mice to
generate p62KI/MVNP mice. These mice developed increased
numbers of pagetic OCL and bone lesions than MVNP mice.
Further, the bone lesions in p62KI/MVNP mice were strikingly
similar to those seen in PD. The p62P392L gene increased RANKLell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc. 23
BA Figure 1. MVNP Expression by p62P392L
Patient Bone Marrow Cells
(A) MVNP mRNA expression in p62P392L PD and
normal nonadherent bone marrow mononuclear
cells (5 3 105 cells) was determined by qRT-PCR
as described in the Experimental Procedures. A
ratio of MVNP/actin <0.3 was considered nega-
tive, and a ratio of R0.3 was considered positive
for MVNP expression.
(B) Detection of MVNP protein in human and
murine OCL with an anti-MVNP monoclonal anti-
body (2D7, Abcam) or control IgG. Cross-reac-
tivity with the anti-MVNP Ab stained nuclei brown
in PD patient and MVNP mouse OCL. The arrows
show nuclei in OCL that did not react with anti-
MVNP.
See Table S1.
Cell Metabolism
MVNP, SQSTM1/p62, and Paget’s Disease of Bonesensitivity of OCL precursors while MVNP was responsible for
OCL hypermultinucleation, increased TAF-12 expression, and
IL-6 production through enhanced p38MAPK signaling induced
by 1,25(OH)2D3. Loss of IL-6 expression in MVNP mice abro-
gated the formation of pagetic OCL in vitro.
RESULTS
OCL Formation in Marrow Cultures from PD Patients
and Normals
Marrow samples from involved or uninvolved bones of 12 PD
patients harboring the p62P392L mutation and eight age-matched
controls were tested for MVNP expression (see Table S1 avail-
able online). Approximately half of the PD patients had elevated
serum alkaline phosphatase (ALP) levels, and most had polyos-
totic PD.
Marrows from 8/12 PD patients expressed MVNP mRNA (Fig-
ure 1A). In three MVNP+ patients whose involved and uninvolved
sites could both be tested, marrow from both sites expressed
MVNP. In contrast, MVNP was not detected in normals or in
4/12 PD patients, in either clinically involved or uninvolved
bone. The sequence of the MVNP qRT-PCR product from
patient #8, who had the highest MVNP expression, completely
matched residues 1129–1222 of the measles virus mRNA for24 Cell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc.nucleocapsid protein (GenBank acces-
sion number X01999). Immunohisto-
chemical analysis confirmed that OCL
formed from the marrow of MVNP+ PD
patient #8 or MVNP mice expressed
MVNP (Figure 1B). No cross-reactivity to
the MVNP antibody was detected in
OCL derived from normal human marrow
or WT mice.
Effects of 1,25(OH)2D3 and RANKL
on OCL Formation
OCL precursors from p62P392L/MVNP+
patients were hyperresponsive to 1,25
(OH)2D3 (Figures 2A and 3C) and formed
OCL that were hypermultinucleated
compared to those from normals orp62P392L/MVNP- patients (Figure 3D, Table S2). However, both
p62P392L/MVNP+ and p62P392L/MVNP- OCL precursors were
hyperresponsive to RANKL and formed more OCL than normals
(Figures 2B and 3C). Nuclear number/OCL in p62P392L/MVNP–
and normal marrow cultures treated with 1,25(OH)2D3 or RANKL
did not differ, and were significantly lower than in p62P392L/
MVNP+ cultures (Figure 3D).
Effects of an Antisense-MVNP on OCL Formation
by MVNP+ and MVNP– Patients or Normals
Transfection of p62P392L/MVNP+ OCL precursors with an
AS-MVNP construct decreased expression of MVNP mRNA by
nearly 70% (Figure 3A) and also resulted in an 80% reduction
in TAF12 expression (Figure 3B) as well as significant reductions
in OCL formation (Figure 3C), nuclei/OCL (Figure 3D), and IL-6
production (Figure 3E) induced by 1,25(OH)2D3, compared to
the scrambled control antisense construct (AS-CONT). Further,
the OCL that formed were normal morphologically (Figure 3F).
AS-MVNP also inhibited the increased bone resorption seen in
marrow cultures from p62P392L/MVNP+ PD patients when
compared to normal OCL (Figures 3G and 3H). AS-MVNP had
no effect on OCL formation, OCL morphology, bone resorption,
or IL-6 production by p62P392L/MVNP– or normal OCL precur-
sors (Figure 3).
A B
Figure 2. OCL Formation Induced by 1,25-(OH)2D3 and RANKL in Marrow Cultures from Affected Bones of p62P392L Patient and Normals
Patient and normal OCL formation induced with (A) 1,25-(OH)2D3 or (B) RANKL and M-CSF. Results are expressed as mean ±SD for quadruplicate cultures.
*p < 0.01 compared to (A) vehicle or (B) M-CSF alone. Two representative patients or normals are shown. Similar results were seen in two independent
experiments using different patients and normals.
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from Mice Coexpressing p62P394L and MVNP,
p62KI/MVNP
To determine the mechanism(s) responsible for the effects of
p62P392L and MVNP on OCL formation and bone remodeling,
knockin mice expressing the p62P394L mutation (p62KI mice)
were bred to transgenic mice expressing MVNP under the
control of the tartrate-resistant acid phosphatase (TRAP)
promoter (MVNP mice) to generate p62KI/MVNP mice, which
were compared to wild-type (WT), MVNP, and p62KI mice.
OCL precursors from MVNP and p62KI/MVNP mice expressed
much higher levels of TAF12 than p62KI or WT mice (Figure 4A),
and were hyperresponsive and formed increased numbers of
OCL when treated with 1,25(OH)2D3, compared to WT or p62KI
mice (Figure 4B). The OCL that formed in marrow cultures from
MVNP and p62KI/MVNP mice were also markedly increased in
size and number (Figure 4C), with increased nuclear numbers
(Figure 4D) compared to p62KI or WT mice. OCL precursors
from p62KI and p62KI/MVNP mice, and to a lesser extent
MVNP mice, were hyperresponsive to RANKL compared to WT
mice (Figure 4B).CSimilar effects of genotype on bone resorption area in marrow
cultures were also seen (Figures 4E and 4F). OCL formed in
marrow cultures from MVNP or p62KI/MVNP, but not p62KI or
WT mice, displayed a marked increase in bone resorption
when the cultures were treated with 1,25(OH)2D3 (10
8 M).
However, OCL in marrow cultures from mice of all three trans-
genic or KI genotypes resorbed more dentin than OCL from
WT cultures when treated with RANKL (50 ng/ml), reflecting their
increased OCL formation.
OCL from both MVNP and p62KI/MVNP mice secreted
high levels of IL-6 in response to 1,25(OH)2D3 compared to
OCL generated from p62KI or WT mice (Figure 4G). RANKL
modestly increased IL-6 production by OCL from all trans-
genic mice. These results indicate that expression of MVNP
in OCL induces hyperresponsivity to 1,25(OH)2D3, hypermulti-
nucleation, and increased IL-6 production, while mutant p62
contributes to increased OCL formation and RANKL respon-
sivity in PD patients and transgenic mice. Further, OCL
from the p62KI/MVNP mice most accurately recapitulate the
phenotypic characteristics of OCL from p62P392L/MVNP+ PD
patients.ell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc. 25
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Figure 3. AS-MVNP Blocks MVNP and TAF12 Expression and Decreases Osteoclast Formation and Bone Resorption by Osteoclast
Precursors from MVNP+ but Not MVNP– PD Patients or Normals
OCL precursors fromMVNP+ and MVNP- patients and normals were transduced with AS-MVNP- or AS-CONT and analyzed for (A) MVNP expression; (B) TAF12
mRNA expression; (C) OCL formation per culture, *p < 0.01 compared to AS-CONT-transduced CFU-GM treated with the same concentration of 1,25(OH)2D3; (D)
nuclei/OCL, results are the average nuclear number in 50 randomly counted OCL, *p < 0.01 compared to no treatment; (E) IL-6 production; (F) OCL morphology,
photomicrograph of OCL in marrow cultures treated with 1,25(OH)2D3 and stained with 23C6 (3100); (G) bone resorption by OCL derived from involved bones of
a MVNP+ patient and normal, *p < 0.05 compared to AS-CONT-transduced cells at the same concentration of 1,25(OH)2D3; (H) photomicrograph of bone resorp-
tion area for (G) (3100). Data in (C)–(E) represent the mean ±SD of aggregate data from three MVNP+ patients, three MVNP– patients, and four normals.
See Table S2.
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on Bone In Vivo
Table S3A depicts the number, age, and sex of the animals that
were subjected to histological and histomorphometric analysis.
In L1-L4 lumbar vertebrae without lesions (see below) from
MVNP, p62KI, p62KI/MVNP, and WT mice aged 12–14 months,
there were no significant differences in the cancellous bone
volume, trabecular width, number, and separation (Table 1).
Cancellous bone structural variables by 2D histomorphometry
in L1-L4 were correlated (p < 0.001) with those by 3D microCT
in the fifth lumbar vertebra of eight mice and in the tibia of ten
mice (data not shown). Although OCL perimeter is increased
slightly in MVNP, p62KI, and p62KI/MVNP mice compared to
WT, these increases are not statistically significant. This likely
reflects the small group size and large variation in OCL perim-
eter, given that we were able to demonstrate a significant26 Cell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc.increase of OCL in MVNP compared to WT mice with 16–24
mice in each of the groups in the MVNP/IL6-KO experiments
(Table S4). Measurement of serum CTX and OCN in transgenic
andWTmice showed that both CTX and OCN levels were signif-
icantly increased in mice expressing MVNP (Figure S1A), while
only CTX was increased in p62KI mice.
Mineral apposition rate was modestly increased in the p62KI/
MVNP mice, while p62KI mice showed modest increases in
mineralizedperimeter andbone formation rate,with similar trends
seen inMVNP and p62KI/MVNPmice. There were no differences
in mineralized perimeter, mineral apposition rate, and bone
formation rate between MVNP and p62KI/MVNP mice (Table 1).
Despite the lack of significant differences in most histomor-
phometric parameters among the different genotypes, dramatic
bone lesions were found within vertebral bone in 4/10 p62KI/
MVNP mice aged 18–26 months and in 1/17 p62KI/MVNP
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Figure 4. Expression of MVNP, TAF12, and Characterization of OCL Formation Induced by 1,25(OH)2D3 and RANKL in Marrow Cultures from
Affected Bones of p62KI, MVNP, p62KI/MVNP, and WT Mice
(A) Expression of MVNP and TAF12. CD11b-positive marrow mononuclear cells from MVNP, p62KI, p62KI/MVNP, and WT mice were cultured with 10 ng/ml of
M-CSF with in 10% FBS and aMEM for 3 days. The nuclear extract (30 mg of protein/lane) was prepared and subjected to immunoblot analysis using antibodies
recognizing anti-MVNP (clone 2D7, Abcom) and anti-TAF12 (Protein Tech). Anti-TFIIB (Santa Cruz) is shown as a loading control.
(B) OCL formation. *p < 0.01 compared to WT at the same concentration of 1,25(OH)2D3 or RANKL.
(C and D) (C) Morphology and (D) nuclear number/OCL in marrow cultures from MVNP, p62KI, p62KI/MVNP, and WT mice. Asterisk indicates significantly
different from 1,25(OH)2D3 or RANKL treatment group, p < 0.01.
(E) OCL formation by MVNP, p62KI, p62KI/MVNP andWT OCL precursors (top). *p < 0.01 compared with WT cultures. Resorption area per dentin slice (bottom).
*p < 0.05 compared with results from WT cultures.
(F) Resorption lacunae formed by OCL on dentin. Original magnification, 3100.
(G) IL-6 production in bone marrow cultures from MVNP, p62KI, p62KI/MVNP, and WT mice. Results for (B), (D), (E), and (G) are expressed as the mean ±SD for
aggregate data from three independent experiments.
See Figures S1A and S1B.
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lesions, the lesions were seen in all four vertebrae examined.
Lesions were not observed in any other group. The morphology
of the bone lesions compared with that of normal bone in a WT
mouse and a pagetic lesion in a patient is shown in Figure 5.
Morphologically, the lesions in the p62KI/MVNP mice (Figures
5B, 5C, 5F, 5G, 5J, and 5K) differed strikingly from normal
bone (Figures 5A, 5E, and 5I). The lesions were characterized
by numerous abnormal OCL, which were large in size, multinu-
clear, and either in deep resorption cavities or detached from
bone. Trabeculae were irregularly thickened and composed
primarily of woven bone, and there was extensive marrowCfibrosis (Figures 5C, 5F, 5G, 5J, and 5K). In focal areas, the
lesions completely replaced cancellous and cortical bone tissue.
There were no detectable differences in the bone lesions
between p62KI/MVNP mice that were heterozygous (n = 3) or
homozygous for p62P394L (n = 2). Thus, coexpression of MVNP
and p62P394L in mice results in histologic lesions that are strik-
ingly similar to PD (Figures 5D, 5H, and 5I).
MAPKs and NFkB Signaling in OCL Precursors Treated
with RANKL or 1,25(OH)2D3
To determine the mechanism(s) responsible for the effects of
MVNP and p62P394L on the abnormal OCL formation and activityell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc. 27
Table 1. Lumbar Vertebral Bone Structure and Remodeling in 12- to 14-Month-Old p62KI/MVNPMice Measured in Vertebrae that Did
Not Contain Paget-like Lesions
No BV/TV Tb.Wi Tb.N Tb.Sp Oc.Pm Md.Pm MAR BFR
Genotype % mm #/mm2 mm % % mm/d mm2/mm/d
WT 5 15.7 30.8 5.1 167.7 17.8 21.7 1.16 0.25
(2.0) (2.4) (0.5) (22.0) (5.6) (3.7) (0.14) (0.07)
MVNP 3 13.2 30.1 4.4 201.1 22.5 32.1 1.34 0.44
(4.1) (8.3) (0.5) (31.2) (12.8) (10.5) (0.18) (0.19)
p62KI Homo 5 17.5 31.6 5.3 182.8 20.0 33.1a 1.10 0.37
(10.2) (6.1) (2.0) (90.6) (8.9) (11.3) (0.24) (0.17)
p62KI Heter 12 19.6 34.1 5.6 159.2 25.3 31.4a 1.35 0.44a
(7.3) (5.4) (1.7) (65.4) (10.3) (6.9) (0.24) (0.16)
p62KI Homo/MVNP 8 14.5 33.4 4.2 219.3 26.0 29.3 1.40a, b 0.40
(6.3) (6.9) (1.1) (68.3) (8.4) (9.5) (0.19) (0.11)
p62KI Heter/MVNP 6 14.9 33.1 4.6 189.2 21.9 21.9 c 1.17 0.26 c
(2.8) (8.8) (0.8) (31.3) (13.9) (9.1) (0.13) (0.12)
Data are expressed as mean (SD).
a p < 0.05 versus WT.
b p < 0.05 versus p62KI Homo.
c p < 0.05 versus p62KI Heter.
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in OCL formation were analyzed. p38 MAPK activation in
response to RANKL was increased in OCL precursors from
MVNP, p62KI, and p62KI/MVNP compared to WT mice. In
contrast, 1,25(OH)2D3 only increased p38 MAPK activation in
mice expressing the MVNP gene (Figure 6A). NFkB, Erk1/2,
and JNK responses were similar in MVNP, p62KI, p62KI/
MVNP, and WT mice in response to 1,25(OH)2D3. However,
NFkB signaling was increased in transgenic mice bearing
p62P394L in response to RANKL (Figure S1B).
Since MVNP was responsible for the enhanced 1,25(OH)2D3
responsivity, hypermultinuclearity, and increased IL-6 produc-
tion by OCL precursors from p62KI/MVNP mice, and MVNP
increased p38MAPK activity to a greater extent than p62P394L,
the effects of blocking p38MAPK activity with SB203580 in
OCL precursors from MVNP mice were examined. Inhibiting
p38MAPK activity blocked the increased OCL formation and
IL-6 production by OCL, as well as hypermultinuclearity of OCL
(Figure 6B). In contrast, blocking NFkB signaling with a NEMO
inhibitory peptide in cultures treated with 1,25(OH)2D3 did not
affect OCL formation (data not shown).
Role of IL-6 in the Effects of MVNP
Because high levels of IL-6 are induced in MVNP but not p62KI
OCL, the role of IL-6 in the multiple effects of MVNP on OCL
formation was determined by breeding MVNP to IL-6 global
knockout (IL-6KO) mice (Kopf et al., 1994). In contrast to
MVNP mice, OCL precursors from MVNP/IL-6KO mice were
not hyperresponsive to 1,25(OH)2D3 (Figure 6C), expressed low
levels of TAF-12 (Figure 6D), and formed OCL that contained
a similar number of nuclei/OCL as WT mice (data not shown).
Histomorphometric analysis of WT, MVNP, IL-6KO, and
MVNP/IL-6KO mice revealed no significant differences in
cancellous bone volume, trabecular width, number, and separa-
tion in the lumbar vertebral bodies (Table S4). MVNP mice
showed a significant increase in OCL perimeter and mineral28 Cell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc.apposition rate and displayed a trend toward increases in miner-
alized perimeter and bone formation rate, while IL-6KO mice
showed a significant decrease in mineralized perimeter and
bone formation rate, and a trend toward decrease in mineral
apposition rate. MVNP/IL-6KO mice showed a significant
increase in OCL perimeter similar to that in MVNP mice, but
mineralized perimeter and bone formation rate were reduced in
MVNP/IL-6KO mice, similar to IL-6KO mice.
DISCUSSION
Both genetic and environmental etiologies have been proposed
for PD. However, their relative contributions to the pathogenesis
of PD are unclear. Therefore, we examined 12 PD patients
harboring the p62P392L mutation for expression of MVNP, and
studied mice coexpressing MVNP and p62P394L, to address this
question. MVNP was expressed in marrow from 8/10 patients
for whom specimens from involved sites were available (Table
S2), similar to our previous results (Reddy et al., 1995). Most
patients (six out of eight) with elevated ALP levels were MVNP+,
while two out of four patients with normal ALP levels were
MVNP+. Interestingly, in three out of three MVNP+ patients for
which specimens from both involved and involved sites were
available, the uninvolved specimen also expressed MVNP.
Several possibilitiescouldexplain this result: (1)MVNPexpression
in uninvolved bone may represent areas of subclinical PD, where
there are very low numbers of pagetic OCL. Clinically detectable
PD lesions may only develop when large numbers of pagetic
OCL are present. This could require many years to occur, since
PD patients rarely develop new lesions during the long course of
their disease. (2) MVNP+ patients may have circulating MVNP+
precursors, which are present in peripheral blood admixed with
the marrow aspirates. Low numbers of MVNP+ cells have been
detected in the blood from PD patients (Reddy et al., 1999).
OCL precursors from all MVNP+ patients formed pagetic OCL
in vitro, whichwere hyperresponsive to 1,25(OH)2D3 and RANKL,
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Figure 5. Histological Microphotographs of
Paget’s-like Lesions in Vertebrae from
p62KI/MVNP Mice Compared with the
Vertebra from WT and the Bone Lesions
from a Patient with Paget’s Disease
Photos from top to bottom rows were taken from
vertebral bone of a WT mouse in the first row
(A, E, I), a p62 3 MVNP homozygous mouse in
the second row (B, F, J), and a p62 3 MVNP
heterozygous mouse in the third row (C, G, K)
(TRAP stain); the fourth row (D, H, L) shows bone
lesions from a patient with PD (Goldner’s tri-
chrome stain). Photos from left to right columns
were taken under bright light with a magnification
of 633 (left, A, B, C, D) or 4003 (middle, E, F, G,
H), or polarizing light with 4003 (right, I, J, K, L).
The first row demonstrates normal cancellous
and cortical bone (A), osteoclasts (E) and the
lamellar pattern of bone (I) in the WT mouse. The
second displays diffuse osteolytic lesions within
the cancellous bone/marrow compartment and
invading cortical bone and growth plate, loss of
trabecular microstructure with, and irregular thick
trabeculae and cortical thinning (B); extremely
numerous, large, and multinuclear osteoclasts
(red) are attached to the bone or in fibrotic marrow
(F); and the bone is woven (J) in the p62 3 MVNP
homozygous mouse. The third row shows a local-
ized lesionwithin the cancellous/marrow compart-
ment (C); osteoclasts are numerous, large, and
multinucleated, both attached and detached
from bone, with marrow fibrosis (G); and the
bone matrix is comprised of woven bone (K) in
the p623MVNP heterozygous mouse. The fourth
row demonstrates classical Paget’s lesions: irreg-
ular thickened woven bone with ‘‘mosaic’’ pattern,
numerous extremely large osteoclasts with many
nuclei in deep resorption cavities or detached
from bone, plump osteoblasts on osteoid, and
marrow fibrosis (D, H, L).
See Tables S3A and S3B.
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elevated levels of TAF12. In contrast, OCL precursors from
MVNP– patients were not hyperresponsive to 1,25(OH)2D3, ex-
pressed normal levels of TAF12, and formed normal OCL. OCL
precursors from bothMVNP– andMVNP+ patients were hyperre-
sponsive to RANKL, most likely reflecting the presence of the
p62P392L mutation in all patients, since transfection of p62P392L
into normal human OCL precursors or introduction of the
p62P394L mutation into mice results in hyperresponsivity of
OCL precursors to RANKL. Further, like the MVNP– patients,
OCL frommarrow cultures of p62KI mice did not display features
characteristic of PD (Hiruma et al., 2008; Kurihara et al., 2007).
The lack of TAF12 expression and hypersensitivity to 1,25
(OH)2D3 in p62
P392L/MVNP– patients supports previous reports
that normal OCL precursors transfected with p62P392L form
normal levels of OCL with normal ratios of nuclei/OCL when
treated with 1,25(OH)2D3 (Hiruma et al., 2008; Kurihara et al.,C2007). These results suggest that expression of MVNP in OCL
precursors is required for formation of OCL expressing a pagetic
phenotype in vitro. Consistent with these observations, expres-
sion of MVNP but not p62P392L in OCL precursors is sufficient
to induce normal OCL precursors to form pagetic OCL and
develop pagetic bone lesions in mice (Kurihara et al., 2006,
2007).
Interestingly, marrow from MVNP– PD patients, like normal
donors, formed OCL that were morphologically normal rather
than pagetic, even though the patients have documented PD.
The basis for this lack of a PD phenotype in OCL formed
in vitro by this subset of patients is unknown. The lack of
MVNP expression in some patients suggests that other factors,
including viruses or genes, may be involved in the development
of PD in MVNP– patients. For example, we did not screen for
respiratory syncytial virus (RSV), which has also been frequently
detected by immunohistochemistry in OCL from PD patientsell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc. 29
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Figure 6. Role of p38MAPK Activation in the Effects of MVNP on Pagetic OCL Formation
(A) Analysis of p38 MAPK activation in MVNP, p62KI, p62KI/MVNP, and WT OCL precursors. Lysates from OCL precursors of transgenic or WT mice were
induced with RANKL or 1,25(OH)2D3, for the time periods indicated, the lysates prepared, and p38MAPK activation determined by western blot analysis as
described in the Experimental Procedures. Similar results were seen in three independent experiments.
(B) Effects of blocking p38MAPK signaling with a p38 inhibitor (SB203580) in MVNP expressing OCL precursors on IL-6 production, OCL formation, and nuclei/
OCL. OCL formation and IL-6 in conditioned media were determined as described in the Experimental Procedures. Results are expressed as the mean ±SD for
four technical replicates. Asterisk indicates significantly different than cells without SB, p < 0.01.
(C) OCL formation by marrow from MVNPmice lacking IL-6. MVNP mice were interbred with IL-6KO mice and marrow from offspring of the indicated genotypes
were tested for pagetic OCL formation. Results are expressed as the mean ±SD for three independent experiments. Asterisk indicates significantly different from
WT cultures, p < 0.01.
(D) TAF12 expression by MVNP/IL-6KO mice.
See Table S4.
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in these patients.
Transfection ofOCLprecursors fromp62P392L/MVNP+patients
with AS-MVNP significantly decreasedMVNP expression, result-
ing in a corresponding decrease in TAF12mRNAexpression, IL-6
production, and hypersensitivity to 1,25(OH)2D3, and generated
OCL with a normal morphology. AS-MVNP had no effect on
OCL formation from p62P392L/MVNP– patients or normals.
Increased expression of TAF12 and IL-6 and 1,25(OH)2D3 hyper-
responsivity ofOCLprecursors are consistent findings inmostPD
patients with either familial or sporadic PD (Kukita et al., 1990;
Mossetti et al., 2005; Neale et al., 2000; Roodman et al., 1992).
These results demonstrate that expression of MVNP in OCL of
PDpatientswith p62P392L is responsible for the increased expres-
sion of TAF12 and 1,25(OH)2D3 hyperresponsivity of their OCL
precursors. The results also suggest that the high IL-6 levels
found in marrow and plasma from PD patients (Mossetti et al.,
2005; Roodman et al., 1992) result from expression of MVNP or
other environmental factors in PD patients, rather than from the
p62 mutations linked to PD.
BothMVNP+ andMVNP–PD patients were hyperresponsive to
RANKL and formed increased numbers of OCL at lower levels of30 Cell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc.RANKL than normal OCL precursors. Transfection of MVNP+ or
MVNP– OCL precursors with an antisense-MVNP had no effect
on the increased OCL formation in response to RANKL. These
results suggest that p62P392L is responsible for the hyperrespon-
sivity of OCL precursors to RANKL regardless of their MVNP
status.
Further, the bone resorbing capacity of OCL formed in marrow
cultures from p62P392L/MVNP+ patients was increased as com-
pared to OCL formed by p62P392L/MVNP– or normal OCL precur-
sors. This most likely reflects that MVNP– OCL were smaller and
had fewer nuclei/OCL compared to MVNP+ OCL, since multinu-
cleation enhances the bone resorption capacity of cells (Yagi
et al., 2005). These results suggest that MVNP enhances OCL
precursor fusion to form hypermultinucleated OCL with an
increased bone resorbing capacity in PD.
In support of our findings in PD patients, OCL formation in
bone marrow cultures of p62KI/MVNP mouse OCL precursors
was greatly enhanced, the OCL were hypermultinucleated, and
the OCL precursors were hyperresponsive to 1,25(OH)2D3 as
compared to p62KI or WT mice (Figure 4). Further, the bone
resorption capacity was enhanced in p62KI/MVNP cultures.
CTX levels were also increased in the serum of MVNP, p62KI,
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previous studies that showed that MVNP and p62P394L induce
increased levels of OCL formation (Kurihara et al., 2004; Mills
et al., 1994). MVNP expression in OCL precursors upregulated
TAF12 and made these cells hyperresponsive to 1,25(OH)2D3
as well. OCL precursors from p62KI/MVNP and p62KI mice
were more hyperresponsive to RANKL than MVNP mice. IL-6
levels were also increased in marrow cultures of MVNP and
p62KI/MVNP mice compared to p62KI mice (Figure 4G). The
basis for the increased IL-6 secretion most likely reflects the
increased p38MAPK activation by 1,25(OH)2D3 in MVNP-ex-
pressing cells (Figure 6B) (Kurihara et al., 2009).
Our histological finding that the p62KI/MVNP mice developed
pagetic-like lesions is consistent with our in vitro OCL formation
results. Forty percent of the p62KI/MVNP mice aged 18–
26 months showed dramatic bony lesions in their lumbar verte-
brae and in two of these animals, multiple vertebrae were
affected. These lesions, which were more common in the older
animals, had many characteristic features of PD, including
a dramatically increased number of hypermultinucleated OCL;
irregularly thickened, coarse trabeculae composed primarily of
woven bone; large lytic regions in both trabecular and cortical
bone; and extensive marrow fibrosis. Further, osteocalcin levels
were only elevated in MVNP and p62KI/MVNP mice, consistent
with our current and previous histologic results that showed
increased bone formation in mice expressing MVNP (Kurihara
et al., 2006). Our histomorphometric findings in the p62KI/
MVNP mice were also consistent with a pagetic phenotype
showing generalized increase in bone turnover, bearing in mind
that the histomorphometry was performed on bones without
lesions. In this nonlesioned bone MVNP increased osteoclast
perimeter by 26% (not statistically significant) in the p62KI/
MVNP experiments (Table 1). However, MVNP increased osteo-
clast perimeter by 23% (statistically significant) in theMVNP/IL-6
KO experiments (Table S4) and by 57% (statistically significant)
in our previous study (Table 3 in (Kurihara et al., 2006) compared
to WT mice. The reason for the lack of statistical significance in
the p62KI/MVNP experiment could be related to the small group
sizes for MVNP (n = 3) and WT (n = 5) mice in Table 1 and the
large variation in osteoclast perimeter. This compares with
sample sizes of 12–24 in the studies where a significant effect
of MVNP on osteoclast perimeter was seen. It is important to
note here that the quantitative histomorphometry was performed
on bone without lesions and therefore the effects of MVNP on
bone remodeling would be expected to be less pronounced.
Bone remodeling in nonlesioned bone in patients with PD is
only slightly elevated. It is not clear why we did not find lesions
in the MVNP alone animals in the present study, but as this
occurs in 29% of MVNP animals, this too may be a sampling
issue.
Mineralized perimeter, determined by the use of calcein
labeling, was significantly increased in p62KI mice, and
mineral apposition rate was increased in p62KI/MVNP. The
high correlations between structural variables, determined by
histomorphometry and microCT at different skeletal sites,
suggest a generalized expression of the phenotype.
We then examined the mechanisms responsible for MVNP’s
capacity to induce a pagetic phenotype in MVNP and p62KI/
MVNP mice. As shown in Figure 6, MVNP increased p38MAPKCactivity in response to 1,25(OH)2D3 to a greater extent than
p62P394L. Further, blocking p38MAPK activity decreased OCL
numbers, 1,25(OH)2D3 hypersensitivity, formation of hypermulti-
nucleated OCL, and IL-6 production.
Several studies have shown that MVNP can increase IL-6
expression when introduced into cells (Helin et al., 2001; Man-
chester et al., 1999; Schneider-Schaulies et al., 1993). In addi-
tion, IL-6 is a potent inducer of OCL formation (Kurihara et al.,
1990), and high levels of IL-6 increase the number of nuclei/
OCL in the presence of low levels of 1,25(OH)2D3 (Kurihara
et al., 1991). Therefore, to determine if the increased expression
of IL-6 by OCL expressing MVNP is responsible for the abnormal
OCL activity that we found, we bred MVNP mice to global IL-6
KO mice. The OCL formed from marrow cultures of MVNP/IL-
6KO mice cultured in the presence of 1,25(OH)2D3 did not
display the characteristics of pagetic OCL. Further, histomor-
phometric analysis of bones from MVNP/IL-6KO mice revealed
that loss of IL-6 also abrogated the increase in mineral apposi-
tion rate found in MVNP mice and reduced mineralizing perim-
eter and bone formation rate. Taken together, these results
support that IL-6 is an inducer of the pagetic OCL phenotype
and contributes to PD.
The results of our studies suggest that the p62P392L mutation
and other genetic mutations linked to PD increase OCL forma-
tion and activity. Like our studies with transgenic p62P392L
mice (Kurihara et al., 2007), Custer et al. recently reported that
transgenic mice expressing the mutant VCP gene linked to PD
also have increased OCL formation and develop progressive os-
teopenia rather than PD (Custer et al., 2010). Genetic mutations
linked to PD appear to predispose patients to PD but require co-
expression of an environmental factor in OCL precursors for the
development of a robust pagetic phenotype. In support of this
conclusion, Gennari et al. recently reported that there is a strong
association between environmental factors and the develop-
ment of severe PD in patients with a genetic predisposition to
PD (Gennari et al., 2010).
Thus, MVNP contributes to the abnormal OCL activity in most
but not all the patients with p62P392L mutations we studied, sug-
gesting that there are two types of patients with PD. In one, OCL
precursors express MVNP and form OCL in vitro, characteristic
of pagetic OCL, while in the second, the OCL precursors lack
MVNP and form normal-appearing OCL in vitro. These results
further suggest that p62P392L enhances the osteoclastogenic
capacity of PD patients through enhanced RANKL sensitivity,
but that a second stimulus is required for the formation of OCL
characteristic of PD (Kurihara et al., 2007). This second stimulus
in the MVNP– patients could be another virus or environmental
factor analogous to MVNP, or another mutated gene.EXPERIMENTAL PROCEDURES
Patients and Age-Matched Healthy Controls
Bone marrow was obtained from involved and uninvolved posterior iliac crests
of 12 patients with familial PD carrying the p62P392L mutation and six age-
matched controls by Dr. Jacques Brown, shipped at room temperature over-
night, and placed into culture after receipt. The extent and activity of PD was
documented by bone scans, pelvic X-rays, and total ALP measurements
(Laurin et al., 2002). PD was similarly ruled out in controls. All patients and
controls had detectable measles virus IgG antibodies. Prior history of bi-
sphosphonate treatment and clinical status were documented at the time ofell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc. 31
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burgh and Laval University human studies committees.
Detection of Mvnp and Taf12 Mrnas and Sequence Analysis
of the Mvnp Transcript
MVNP and TAF12 mRNA expression was determined by qRT-PCR with
total RNA isolated from primary marrow samples and from AS-MVNP or
AS-CONT transduced cells. The gene specific primers were MVNP,
50-AGTTCCACATTAGCATCTGAAC-30 (sense) and 50-TACTGATCTTGTCCTC
AGTAG-30 (antisense) (GenBank accession number M10297X01999); TAF12,
50-CTCATCCATAAAACCGGAACCA-30 (sense) and 50-TTCAGGGCTAAGACG
ACCTCC-30 (antisense) (GenBank accession number NM 005644); and
b-actin, 50-GTGCGTGACATCAAAGAG-30 (sense) and 50-GCCACAGGATTCC
ATACC-30 (antisense). The MVNP RT-PCR product from PD patient #8 was
cloned into the pCR-TOPO vector (TOPO-TA Cloning Kit, Invitrogen) following
the manufacturer’s protocol. Three independent clones were sequenced
with a M13 forward primer using a CEQ 8000 Automated DNA Sequencer
(Beckman-Coulter), and compared with the MVNP sequence in GenBank
(accession number X01999) using Genetyx software (Software Development
Co. Ltd., Tokyo, Japan).
Immunohistochemical Detection of Mvnp
OCL derived from marrow cultures treated with 108M 1,25(OH)2D3 from
a normal individual and PD patient #8, and from a WT and an MVNP mouse,
were examined for cross-reactivity with a monoclonal antibody against
MVNP (clone 2D7) (Abcam, Cambridge, MA) as previously described (Kurihara
et al., 2006).
Retroviral Vector Construction and Viral Supernatant Preparation
Recombinant retroviral expression vectors were designed to produce either
a previously validated antisense oligonucleotide targeted to 50 end of the
MVNP mRNA (AS-MVNP) or a scrambled antisense control (AS-CONT) (Bell
et al., 1997). Briefly, the AS-MVNP oligonucleotide (50-CTCGGATATCCCTA
ATCCTGCTCTTGTCCCTGATAATAGGATCTTGAATCCT-30) or the AS-CONT
oligonucleotide (50-AGGATTCAAGATCCTATTATCAGGGACAAGAGCAGGAT
TAGGGATATCCGAG-30 ) was subcloned into the pLXSN retroviral vector.
Recombinant retroviral constructs were transfected into the PT67 ampho-
tropic packaging cell line, and stable clonal cell lines producing recombinant
retroviruses at high titer (106 virus particles/mL) were established by selecting
for G418 (400 mg/ml) resistance as previously described (Kurihara et al., 2000).
AS-MVNP or AS-CONT Transduction of PD and Normal OCL
Precursors
Humanmarrowmononuclear cells isolated from involved sites of three MVNP+
and three MVNP– PD patients, and four normals were cultured for 96 hr with
cytokines and the retroviral supernatant as previously described (Kurihara
et al., 2000). The patient marrows were selected for study because they had
sufficient cell numbers to perform all experiments. The cells were harvested
for short-term CFU-GM clonogenic assays in methylcellulose and transduced
CFU-GM resistant to G418 (400 mg/ml) were then used for the studies below.
Long-Term Culture of OCL Precursors Transduced with AS-MVNP
or AS-CONT Vectors
AS-MVNP- or AS-CONT-transduced OCL precursor cells (5 3 103 cells/well)
from PD patients or normals were cultured for 7 days with 100 pg/ml recombi-
nant human GM-CSF as reported previously (Kurihara et al., 2000). Cells from
G418-resistant colonies (5 3 103/culture) were individually collected and
cultured forOCL formationwith 1,25(OH)2D3or RANKLasdescribed previously
(Ishizuka et al., 2005). The vitronectin receptor positive multinucleated cells
were scored using an inverted microscope. The IL-6 concentration of condi-
tioned media recovered each week and pooled from individual OCL cultures
was measured using an ELISA kit for human IL-6 (R&D, Minneapolis, MN).
Osteoclastic Bone Resorption on Dentin Slices
AS-MVNP- or AS-CONT-transduced CFU-GM-derived cells (23 106 cells/ml)
were dispersed into a-MEM media containing 20% horse serum, and seeded
onto mammoth dentin slices (Wako Pure Chemical Industries Ltd. Osaka,
Japan) in 96-well multiplates containing 1010 M 1,25(OH)2D3 or 50 ng/ml32 Cell Metabolism 13, 23–34, January 5, 2011 ª2011 Elsevier Inc.RANKL with 10 ng/ml M-CSF to induce OCL formation. After 3 weeks, OCL
were removed and pit areas quantified by image analysis as previously
described (Ishizuka et al., 2005).
Generation of p62KI/MVNP and MVNP/IL-6KO Mice
The Institutional Animal Care and Use Committees at Virginia Commonwealth
University, University of Pittsburgh School of Medicine, and the VA Pittsburgh
Healthcare System approved all animal studies. Transgenic mice expressing
MVNP under the control of the mouse TRAP promoter were previously
described (Kurihara et al., 2006), as were knockin mice carrying a proline-to-
leucine substitution at residue 394 of the endogenous mouse SQSTM1/p62
gene (equivalent to human p62P392L) (Hiruma et al., 2008). To establish a colony
of mice expressing both the MVNP gene and the p62P394L mutant, MVNP
transgenic mice were bred to p62P394L mice. In all subsequent generations,
only one of the parents carried theMVNP transgene, and either or both parents
were heterozygous or homozygous for the p62mutation. All data are frommice
generated from this p62P394L/MVNP colony (not from the parental p62P394L or
MVNP colonies).
Global IL-6KO mice were generated by Kopf et al. (Kopf et al., 1994) and
obtained from The Jackson Laboratory (stock number 002650). Mice were
interbred with MVNP mice as above. All data are from mice generated from
this IL-6KO/MVNP colony (not from the parental colonies).
Mouse Bone Marrow Cultures
CD11b(+) cells (23 105 cells/well) were prepared as previously described and
cultured for 3 days with M-CSF/RANKL or 1,25(OH) 2D3. TRAP-positive cells
containingR3 nuclei were quantitated as described (Kurihara et al., 2006).
Signaling Pathway Activation in OCL Precursor Lysates from p62KI,
MVNP, p62KI/MVNP, or WT Mice
Cell lysates (50 mg) from 1,25(OH)2D3 or RANKL treated OCL precursors of WT
or transgenicmice were subjected to electrophoresis on 7.5%SDS-PAGE and
the proteins transferred to nitrocellulose membranes and incubated in block-
ing solution (5% nonfat dry milk in TBS containing 0.1% Tween-20) for 1 hr to
reduce nonspecific binding. Membranes were then exposed to primary anti-
bodies overnight at 4C, washed three times, incubated with secondary
goat anti-mouse or rabbit IgG HRP-conjugated antibody, and the bands de-
tected by chemiluminescence following the manufacturer’s directions (Bio-
Rad). All blots were densitometrically quantitated and the results expressed
relative to control and normalized to b-actin or TFIID.
Histology Processing, Evaluation, and Histomorphometry
Lumbar vertebrae from 60 mice for the p62KI/MVNP experiment and 61 mice
for the MVNP/IL-6KO experiment were fixed in 10% buffered formalin at 4C.
The first through fourth lumbar vertebrae were decalcified in 10% EDTA at 4C
and embedded in paraffin. The fifth lumbar vertebra was embedded without
decalcification in methyl methacrylate. Frontal sections were obtained from
the decalcified and undecalcified samples. The decalcified sections were
stained for TRAP, and OCL containing active TRAP were stained red as
described by Liu et al. (Liu et al., 2003). The undecalcified sections were left
unstained for the evaluation of fluorescent labels.
All sections were first evaluated by light microscopy, and then histomorpho-
metric analysis was performed on the cancellous bone/marrow compartment
between the cranial and caudal growth plates in the vertebral bodies without
lesions using the OsteoMeasureXP version 1.01 morphometric program
(OsteoMetrics, Inc., Atlanta, GA). Osteoclast perimeter (Oc.Pm) was defined
as the length of bone surface covered with TRAP-positive mono- and multinu-
clear cells. Cancellous bone volume (BV/TV), trabecular width (Tb.Wi), trabec-
ular number (Tb.N), trabecular separation (Tb.Sp), mineralizing perimeter
(Md.Pm), mineral apposition rate (MAR), and bone formation (BFR) were quan-
tified. All variables were expressed and calculated according to the recom-
mendations of the ASBMR Nomenclature Committee (Parfitt et al., 1987).
A transiliac crest bone biopsy was taken from a 58-year-old female patient
with PD in the ilium. The biopsy sample was embedded without decalcification
in methyl methacrylate. The sections were stained with Goldner’s Trichrome or
left unstained. Histological evaluation was performed under bright-field, UV,
and polarized light.
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Significance was evaluated by a two-sided, unpaired Student’s t test or
two-way analysis of variance where indicated. P < 0.05 was considered signif-
icant. The differences in the histomorphometry variables among genotypes
were statistically analyzed using ANOVA with Fisher’s LSD multiple compar-
ison tests, and the relationship of bone structural variables between 2D
histomorphometry and 3Dmicro-CTwas analyzed with linear correlation using
the NCSS 2004 program.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables and one figure and can be
found with this article at doi:10.1016/j.cmet.2010.12.002.
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